-
Listing
-
Trading
Where European Government Bonds meet the futureFixed Income derivativesLer maisTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLer maisEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLer maisEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Ler maisThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLer maisThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Ler maisShaping capital markets for future generations
IPO Biophytis
16/07/2015
EnterNext welcomes Biophytis on Alternext in Paris
Stanislas Veillet, CEO and co-founder of Biophytis, rings the opening bell.
Biophytis specializes in the development of nutraceuticals and drugs with active phytonutriments for the treatment of metabolic and aging diseases.
The company has a portfolio of 2 nutraceutical assets in clinical phase (Quinolia for the treatment of obesity and Bixilia for the protection of the skin from UV rays) and drug candidates in preclinical phase (treatment of sarcopenic obesity and age-related macular degeneration).